Introduction
============

Following uptake or invasion of mammalian host cells, *Salmonella enterica* serovar Typhimurium (sv. Typhimurium) replicates within membrane-bound compartments known as *Salmonella*-containing vacuoles. Acidification of lumen of the *Salmonella*-containing vacuole stimulates expression of genes involved in the assembly of a multiprotein structure that spans the bacterial cell envelope, called the *Salmonella* pathogenicity island 2 (SPI-2)[^2^](#FN3){ref-type="fn"} type III secretion system (T3SS) ([@B1]--[@B3]). This T3SS secretes proteins that assemble a needle structure and a translocon pore in the vacuolar membrane ([@B1]). Sensing of the near-neutral pH of the host cell cytosol by unknown component(s) of the T3SS triggers the dissolution and loss in the bacterial cytoplasm of a T3SS-associated regulatory complex comprising three proteins: SsaL, SpiC, and SsaM ([@B4]). This relieves repression of secretion of ∼25 effector proteins that are translocated across the vacuolar membrane ([@B4]). The effectors have many different functions, affecting immune signaling ([@B5]), bacterial and host cell motility ([@B6], [@B7]), and intracellular replication of bacteria in a variety of host cell types, including epithelial cells and macrophages ([@B8]). As a result, SPI-2 T3SS null mutants are strongly attenuated in virulence in various hosts ([@B9]--[@B12]).

*ssaQ* is the last gene in the *ssaMVNOPQ* operon within SPI-2 ([@B13], [@B14]). The predicted product of *ssaQ* is a member of the FliN/YscQ/Spa33/HrcQ family of flagellum and T3SS proteins ([@B15]). These proteins belong to the conserved essential core of these structures and are thought to constitute a cytoplasmic platform (C-ring) connected to the base of the secretion system ([@B16], [@B17]). In this work, we studied the *ssaQ* gene of sv. Typhimurium. We found that it produces two proteins from one transcript: a protein of the expected size and a second translational product corresponding to the C-terminal 106 amino acids. The tandem translated small protein acts as a chaperone, binding to and stabilizing the larger protein, and is important for the overall efficiency of the secretion system.

EXPERIMENTAL PROCEDURES
=======================

### 

#### Bacterial Strains and Growth Conditions

The sv. Typhimurium strains used in this study are derivatives of wild-type strain 12023 and are listed in [Table 1](#T1){ref-type="table"}. Bacteria were grown in LB medium supplemented with carbenicillin (50 μg/ml), kanamycin (50 μg/ml), chloramphenicol (15 μg/ml), or tetracycline (25 μg/ml) for strains resistant to these antibiotics (Amp^r^, Kan^r^, Cam^r^, and Tet^r^, respectively). To induce SPI-2 gene expression and SPI-2-dependent secretion, bacteria were grown in magnesium minimal medium (MgM)/MES ([@B3]) at pH 5.0 with the corresponding antibiotics when appropriate.

###### 

**sv. Typhimurium strains constructed and used in this study**

  Name    Description                                             Source or Ref.
  ------- ------------------------------------------------------- ----------------
  12023   Wild-type                                               NCTC
  P3F4    *ssrA*::*mTn5* in 12023 (Kan^r^)                        Ref. [@B9]
  HH216   *sseJ-2HA*::*cat* in 12023 (Cam^r^)                     Ref. [@B21]
  HH225   Δ*ssaQ~18--311~*::*Kan* in 12023 (Kan^r^)               This study
  HH226   *sseJ-2HA*::*cat* in Δ*ssaQ~18--311~*::*Kan* mutant     This study
  HH227   Δ*ssaQ~104--223~*::*cat* in 12023 (Cam^r^)              This study
  HH228   *ssaQ* replaced with *ssaQ~M217L~* in 12023             This study
  HH229   *ssaQ* replaced with *ssaQ~Y206oc~* in 12023            This study
  HH230   *sseJ-2HA*::*cat* in HH229                              This study
  HH231   *sseJ-2HA*::*cat* in HH228                              This study
  HH232   *ssaQ* replaced with *ssaQ~M217L~-HA*::*Kan* in 12023   This study

The λ Red recombination system ([@B18]) was used to construct *ssaQ* deletion mutants HH225 and HH227 using primers ssaQd1 and ssaQd2 or primers ssaQd3 and ssaQd4, respectively. Primers are listed in the [supplemental table](http://www.jbc.org/cgi/content/full/M111.278663/DC1). Chromosomal allelic exchange was used to construct *ssaQ~S~* point mutant HH228 or *ssaQ~L~* point mutant HH229. Briefly, *ssaQ* was ligated into pCR2.1-TOPO (Invitrogen) using primers ssaQf and ssaQb to construct pCR-*ssaQ*, followed by site-directed mutagenesis to create pCR-*ssaQ~M217L~* and pCR-*ssaQ~Y206oc~* using primers ssaQ~M217L~f and ssaQ~M217L~b or primers ssaQ~Y206oc~f and ssaQ~Y206oc~b, respectively. Mutant versions of *ssaQ* were subcloned into suicide vector pCVD442 for transferring mutations to HH227 by conjugation, and exconjugants were selected as described previously ([@B19]). Primers ssaQHAf and ssaQdb were used to fuse DNA segments encoding the HA epitope to the 3′ termini of the coding region of *ssaQ* or *ssaQ~L~* in WT or HH228 strains as described previously ([@B20]).

To express *sseJ-2HA* from chromosomal DNA, *sseJ-2HA*::*cat* from HH216 ([@B21]) was transduced into different strains of sv. Typhimurium by phage P22 as described previously ([@B22]). When necessary, the *FRT*-flanked antibiotic resistance cassette was removed after transformation with pCP20 as described ([@B18]).

#### Plasmids

The *spiC* promoter was ligated into pWSK29 ([@B23]) using primers spiCn1 and spiCn2 to create p*spiCpr*. Plasmids p*ssaQ* and p*ssaQ~L~* were constructed by subcloning *ssaQ* and *ssaQ~M217L~* fragments from pCR-*ssaQ* and pCR-*ssaQ~M217L~* into p*spiCpr*. The *ssaQ~S~* gene was amplified using primers ssaQ~S~f and ssaQb and ligated into p*spiCpr* to construct p*ssaQ~S~*. The HA-tagged *ssaQ*, *ssaQ~M217L~*, and *ssaQ~Y206oc~* DNA fragments were amplified from pCR-*ssaQ*, pCR-*ssaQ~M217L~*, and pCR-*ssaQ~Y206oc~* using primers ssaQf and ssaQHAb and ligated into p*spiCpr* to create plasmids p*ssaQ-HA*, p*ssaQ~M217L~-HA*, and p*ssaQ~Y206oc~-HA*. The *ssaQ~LN216~-HA* fragment was amplified using primers ssaQf and ssaQ~LN216~HAb and ligated into p*spiCpr* to construct p*ssaQ~LN216~-HA*. The *ssaQ~L~-T7* fragment was amplified from p*ssaQ~M217L~-HA* using primers ssaQf-SacI and ssaQT7b-SacI and ligated into p*spiCpr*, p*ssaQ~M217L~-HA*, and p*ssaQ~LN216~-HA* to create plasmids p*ssaQ~L~-T7*, p*ssaQ~L~-HA/ssaQ~L~-T7*, and p*ssaQ~LN216~-HA/ssaQ~L~-T7*, respectively. Plasmid p*ssaQ~S~-T7* was constructed by replacing the *cat* gene of pACYC184 ([@B24]) with *ssaQ~S~-T7* following PCR amplification with primers ssaQ~S~f and ssaQT7b. The expression of *ssaQ~S~-T7* is under the control of the constitutive promoter of *cat*.

The PCR products including the promoter region of *ssaM* to the start codon of *ssaQ~S~* (using primers 102ssaM-KpnI and ssaQ~L217~r-XbaI) or beginning from the start codon of *ssaM* to the start codon of *ssaQ~S~* (using primers ssaM-KpnI and ssaQ~L217~r-XbaI), amplified from genomic DNA of sv. Typhimurium strain 12023, were ligated into the KpnI and XbaI sites of pFPV25, a vector carrying promoterless *gfpmut3A* ([@B25]), to create p*102ssaMQ~LN217~* and p*ssaMQ~LN217~*, respectively. To express *ssaQ~S~* with a His~6~ tag, the cleaved *ssaQ~S~* PCR product (using primers ssaQ~S~-EcoRIf and ssaQ~S~-XhoIb) was ligated into pET-22b (Novagen) to construct pET-*ssaQ~S~*. Plasmids constructed as part of this study were verified by DNA sequencing and are listed in [Table 2](#T2){ref-type="table"}. Plasmid p*steC-2HA* was described previously ([@B26]).

###### 

**Plasmids used in this study**

  Name                           Description                                                                                  Source or Ref.
  ------------------------------ -------------------------------------------------------------------------------------------- ----------------
  pWSK29                         pSC101 *ori*, low copy number vector, Amp^r^                                                 Ref. [@B23]
  pFPV25                         Carrying promoterless *gfpmut3A*, Amp^r^                                                     Ref. [@B25]
  pCVD442                        Suicide vector for DNA allelic exchange, Amp^r^                                              Ref. [@B19]
  pACYC184                       p15A *ori*, medium copy number vector, Tet^r^, Cam^r^                                        Ref. [@B24]
  p*spiCpr*                      *spiC* promoter on pWSK29, Amp^r^                                                            This study
  p*ssaQ*                        *ssaQ* gene on p*spiCpr*, Amp^r^                                                             This study
  p*ssaQ-HA*                     *ssaQ-HA* gene on p*spiCpr*, Amp^r^                                                          This study
  p*ssaQ~M217L~-HA*              *ssaQ~M217L~-HA* gene on p*spiCpr*, Amp^r^                                                   This study
  p*ssaQ~Y206oc~-HA*             *ssaQ~Y206oc~-HA* gene on p*spiCpr*, Amp^r^                                                  This study
  p*102ssaMQ~LN217~*             Sequence composed of promoter region of *ssaM* to start codon of SsaQ~S~ on pFPV25, Amp^r^   This study
  p*ssaMQ~LN217~*                Sequence composed of start codon of *ssaM* to start codon of SsaQ~S~ on pFPV25, Amp^r^       This study
  p*ssaQ~L~*                     *ssaQ~M217L~* gene on p*spiCpr*, Amp^r^                                                      This study
  p*ssaQ~S~*                     *ssaQ~S~* gene on p*spiCpr*, Amp^r^                                                          This study
  p*ssaQ~S~-T7*                  *ssaQ~S~-T7* gene on pACYC184, Tet^r^                                                        This study
  p*ssaQ~LN216~-HA*              *ssaQ~LN216~-HA* gene on p*spiCpr*, Amp^r^                                                   This study
  pET-*ssaQ~S~*                  *ssaQ~S~* gene on pET-22b, Amp^r^                                                            This study
  p*ssaQ~L~-T7*                  *ssaQ~L~-T7* gene on p*spiCpr*, Amp^r^                                                       This study
  p*ssaQ~L~-HA/ssaQ~L~-T7*       *ssaQ~L~-T7* gene on p*ssaQ~M217L~-HA*, Amp^r^                                               This study
  p*ssaQ~LN216~-HA/ssaQ~L~-T7*   *ssaQ~L~-T7* gene on p*ssaQ~LN216~-HA*, Amp^r^                                               This study
  p*steC-2HA*                    *steC-2HA* gene with *steC* promoter on pWSK29, Amp^r^                                       Ref. [@B26]

#### Antibodies

The following primary antibodies were used for immunoprecipitation, immunofluorescence staining, and immunoblot analysis: rat anti-HA antibody (3F10, Roche Applied Science); mouse anti-T7 antibody (Novagen); mouse anti-HA monoclonal antibody HA.11 (MMS-101P, Covance); mouse anti-DnaK antibody (Assay Designs); goat anti-*Salmonella* polyclonal antibody CSA-1 (Kirkegaard & Perry Laboratories); and rabbit anti-SseB, anti-SseC, and anti-SseD polyclonal antibodies ([@B21]). Texas Red sulfonyl chloride-conjugated donkey anti-goat antibody (Jackson ImmunoResearch Laboratories) was used for immunofluorescence microscopy. Alexa Fluor 488-conjugated donkey anti-goat antibody and Alexa Fluor 647-conjugated donkey anti-mouse antibody (Invitrogen) were used for flow cytometric analysis. The following HRP-conjugated secondary antibodies were used for immunoblot analysis: donkey anti-rabbit and sheep anti-mouse antibodies (Amersham Biosciences) and rabbit anti-rat antibody (Dako).

#### Preparation of Protein Fractions from Bacteria Grown in Vitro

Bacterial strains were grown in MgM/MES for secretion assays as described previously ([@B4], [@B21]). To ensure that protein from equal numbers of cells was analyzed, in all experiments, protein samples were adjusted to *A*~600~ values such that a volume corresponding to 10 ml of a culture with *A*~600~ = 0.6 was taken up in 100 μl of protein denaturing buffer for secreted and bacterial surface-associated fractions and in 600 μl of protein denaturing buffer for the total bacterial fraction.

#### Immunoprecipitation Assays

Volumes corresponding to 20 ml of a bacterial culture with *A*~600~ = 0.6 after 5 h of growth of sv. Typhimurium in MgM/MES at pH 5.0 were used to perform immunoprecipitation assays. Bacteria were collected by centrifugation and resuspended in a solution comprising 1 ml of 50 m[m]{.smallcaps} glucose, 10 m[m]{.smallcaps} EDTA, 4 mg/ml lysozyme, and 25 m[m]{.smallcaps} Tris-Cl (pH 8.0) and incubated for 5 min at room temperature to generate spheroplasts. The spheroplasts were resuspended into 1.5 ml of lysis buffer (50 m[m]{.smallcaps} Tris-Cl (pH 8.0, 100 m[m]{.smallcaps} NaCl, 1% Triton X-100, and 1 m[m]{.smallcaps} PMSF) and incubated on ice for 30 min with occasional mixing. The lysate was centrifuged for 10 min at 10,000 × *g*, and the supernatant was transferred into a fresh tube and incubated with 50 μl of protein G-immobilized agarose (Pierce) for 1 h to preclear the lysate. The precleared supernatant was incubated with 10 μl of rat anti-HA antibody or mouse anti-T7 antibody for 2 h at 4 °C to form antibody-antigen complexes, and 50 μl of protein G-immobilized agarose was added to the reaction and incubated for 2 h at 4 °C. The beads were collected by centrifugation at 500 × *g* for 4 min and washed four times with 700 μl of lysis buffer prior to boiling in 50 μl of SDS-PAGE sample buffer.

#### N-terminal Sequencing of SsaQ~S~

The bacterial lysate of *ssaQ* p*ssaQ-HA* culture grown in MgM/MES was subjected to immunoprecipitation with rat anti-HA antibody. SsaQ~S~-HA was recovered from the PVDF membrane and sequenced by Edman degradation (Protein & Nucleic Acid Chemistry Facility, University of Cambridge). The first six amino acids obtained for SsaQ~S~ were MKFDEL.

#### Cross-linking and Protein Stability Assays

*Escherichia coli* BL21(DE3) cells containing plasmid pET-*ssaQ~S~* were cultured in LB medium and induced for 2 h at 30 °C with 1 m[m]{.smallcaps} isopropyl β-[d]{.smallcaps}-thiogalactopyranoside to express SsaQ~S~-His~6~. The bacteria were treated with DMSO (Sigma) or the cross-linker disuccinimidyl suberate (1 m[m]{.smallcaps}; Pierce) as recommended by the manufacturer and subjected to Western blotting with HRP-conjugated anti-His antibody (ab1187, Abcam).

For the SsaQ~L~-HA stability assay, bacterial strains were cultured in MgM/MES at pH 5.0 for 4 h, and tetracycline was then added to a final concentration 20 μg/ml to stop protein synthesis. Samples were removed at different time points for immunoblotting.

#### PAGE and Immunoblot Analysis of Proteins

Protein fractions were dissolved in the appropriate volume of protein denaturing buffer and held at 100 °C for 10 min. Proteins were immediately separated on 12% SDS-polyacrylamide gels. For immunoblot analysis, proteins were transferred to Immobilon-P (PVDF) membranes (Millipore) and examined using the ECL detection system (Amersham Biosciences) under conditions recommended by the manufacturer. Incubation of membranes with primary antibodies was followed by incubation with HRP-conjugated secondary antibodies.

#### Cell Culture, Immunofluorescence, and Flow Cytometric Analysis

HeLa epithelial cells (clone HtTA1) were grown in DMEM (Invitrogen) supplemented with 10% FCS and 2 m[m]{.smallcaps} glutamine at 37 °C in 5% CO~2~ and infected with exponential phase sv. Typhimurium as described previously ([@B27]).

To visualize GFP expression, HeLa cells were fixed with 3% paraformaldehyde at 5 h post-invasion. Bacteria were labeled first with antibody CSA-1 and then with Texas Red sulfonyl chloride-conjugated donkey anti-goat antibody. Images were taken on a Zeiss LSM 510 confocal laser scanning microscope.

To detect translocation of SseJ-2HA, HeLa cells infected with *Salmonella* strains for 13 h were trypsinized and then fixed with 3% paraformaldehyde. Antibodies CSA-1 and HA.11 were used to label bacteria and translocated SseJ-2HA in the presence of 0.1% saponin (Sigma), followed by labeling with secondary antibodies conjugated to Alexa Fluor 488 or 647. Approximately 1 × 10^5^ infected cells were analyzed on a FACSCalibur cytometer (BD Biosciences), and bacteria and SseJ-2HA were detected at 525 nm in the FL1 channel and at 633 nm in the FL4 channel. Data were analyzed with FlowJo 8.8.6 software.

#### Bioinformatic Analysis and Homology Modeling

Homology models of SsaQ~S~ were calculated using the Phyre protein structure prediction server ([@B28]). The homology model of SsaQ~S~ was calculated from the primary amino acid sequence of the flagellar rotor protein FliN from *Thermotoga maritima* ([@B29]). The SsaQ~S~ sequence was aligned, submitted to multiple secondary structure prediction, and compared against the Phyre fold library. The top 10 alignments were used to produce an ensemble of three-dimensional models. The top-scoring Phyre homology model was used as the representative monomer structure, and a final model for the dimer was assembled by superposition on the dimer of FliN. ClustalW2 was used to align the two protein sequences.

#### Mouse Mixed Infections

Female BALB/c mice (20--25 g) were used for competitive index (CI) studies. Four mice were inoculated intraperitoneally with a mixture of two strains comprising 500 colony-forming units of each strain in physiological saline, and the CIs were determined from spleen homogenates 96 h post-inoculation as described previously ([@B30]). The *p* value was determined by two-tailed *t* test.

RESULTS
=======

### 

#### Products of SsaQ

SsaQ is encoded by SPI-2 and shares weak overall similarity (14.6% identity and 38.5% similarity) with Spa33, the C-ring protein of the *Shigella* T3SS ([@B16]). The C-ring proteins show greater conservation in the C-terminal regions, and an alignment of this region revealed several conserved residues that are also found in SsaQ ([@B15]). To investigate the function of SsaQ in SPI-2 type III secretion, an *ssaQ* deletion mutant with the chromosomally encoded epitope-tagged effector SseJ-2HA was constructed and analyzed. In minimal medium at pH 5.0, the SPI-2 T3SS is activated and secretes high levels of translocon proteins and very low levels of effectors ([@B3], [@B4]). Under these conditions, secretion of the translocon protein SseB and SseJ-2HA from the mutant strain was undetectable, and this phenotype was complemented by introduction of a plasmid expressing wild-type SsaQ ([Fig. 1](#F1){ref-type="fig"}*A*).

![**Analysis of *ssaQ* gene products and their function.** *A*, essential role of SsaQ in secretion of SseB and SseJ. Bacterial strains expressing SseJ-2HA from the chromosome were grown in MgM/MES at pH 5.0 for 5 h, and whole bacterial cell lysates and secreted fractions were subjected to immunoblot analysis. The intrabacterial protein DnaK was used as a control. *B*, neither SsaQ~L~-HA nor SsaQ~S~-HA was secreted or presented on the bacterial surface. Plasmid p*ssaQ-HA* was transformed into the *ssaQ* mutant (HH225) for analysis. Bacterial surface proteins were extracted with *n*-hexadecane. *C*, the promoter upstream of *ssaM* is the only one driving expression of the *ssaMVNOPQ* operon. The schematic illustrates the plasmids used in the transcriptional assay. The confocal micrographs show HeLa cells infected with the indicated bacterial strains for 5 h. *Green*, GFP; *red*, CSA-1-labeled bacteria. *Scale bar* = 5 μm. *D*, SsaQ~S~-HA is a translated product rather than a cleavage product of SsaQ~L~-HA. The *ssaQ* mutant (HH225) was transformed with different plasmids and grown in MgM/MES at pH 5.0 for 5 h, and whole bacterial cell lysates were subjected to immunoblot analysis. *E*, SsaQ~L~, but not SsaQ~S~, is essential for secretion of SseB and SseJ. The *ssaQ* mutant expressing SseJ-2HA from chromosomal DNA (HH226) was transformed with the indicated plasmids and used for analysis.](zbc0481183410001){#F1}

As well as being a component of the C-ring, Spa33 has been proposed to be a secreted substrate of the T3SS ([@B31]). To determine whether SsaQ is secreted, a plasmid expressing C-terminally HA-tagged SsaQ (SsaQ-HA) was introduced into the *ssaQ* deletion mutant. SsaQ-HA was functional, as shown by its ability to restore SseB secretion in minimal medium at pH 5.0 ([Fig. 1](#F1){ref-type="fig"}*B*). However, under these conditions, SsaQ-HA was not detected in culture supernatants or on the bacterial cell surface ([Fig. 1](#F1){ref-type="fig"}*B*). Interestingly, two proteins were detected in the bacterial lysate with an anti-HA antibody. One corresponds to the expected mass of SsaQ (36 kDa), and the other is ∼12 kDa. The small protein was not due to the overexpression of SsaQ-HA from the plasmid, as it was also detected when SsaQ-HA was expressed from chromosomal DNA (data not shown). To establish the identity of the small protein, it was gel-purified and subjected to N-terminal sequencing. This revealed that it comprises the C-terminal 106 amino acids of SsaQ, with Met-217 of SsaQ at its N terminus. The full-length protein was designated SsaQ~L~, and the smaller protein was designated SsaQ~S~.

The expression of *ssaQ* is controlled by a promoter of the 5.4-kb *ssaMVNOPQ* operon ([@B13], [@B14]). To determine whether SsaQ~S~ is derived from an independent transcript, DNA fragments either including the 102-bp promoter sequence upstream of *ssaM* or beginning from the start codon of *ssaM* to the putative start codon of *ssaQ~S~* were ligated into a *gfp* reporter plasmid to generate plasmids p*102ssaMQ~LN217~* and p*ssaMQ~LN217~* respectively ([Fig. 1](#F1){ref-type="fig"}*C*). The plasmids were transformed into sv. Typhimurium strains, which were then used to infect HeLa cells for 5 h. There was no detectable GFP fluorescence in bacterial cells carrying the plasmid lacking the 102-bp promoter sequence. GFP production was observed in \>90% of bacterial cells containing the 102-bp promoter sequence and was completely dependent on the SPI-2 two-component regulatory system SsrA-B ([Fig. 1](#F1){ref-type="fig"}*C*) ([@B32]). These results indicate that both SsaQ~L~ and SsaQ~S~ are translated from the *ssaMVNOPQ* transcript.

To determine whether SsaQ~S~ is a cleavage product of SsaQ~L~ or is translated separately, *ssaQ-HA* was subjected to site-directed mutagenesis, and the effects were examined following production of mutant proteins from a plasmid in an sv. Typhimurium *ssaQ* null mutant strain grown in minimal medium at pH 5.0. If SsaQ~S~ is the product of cleavage of SsaQ~L~, then it should not be produced if SsaQ~L~ is truncated before Met-217. Therefore, the codon for Tyr-206 of SsaQ~L~-HA was replaced with a stop codon (ochre mutation, TAA). As expected, SsaQ~L~-HA was not detected upon expression of SsaQ~Y206oc~-HA, but SsaQ~S~-HA was still produced by this mutant ([Fig. 1](#F1){ref-type="fig"}*D*). Substituting the codon for Met-217 (the putative start codon for SsaQ~S~) with a leucine codon (SsaQ~M217L~) resulted in an absence of SsaQ~S~-HA but not SsaQ~L~-HA ([Fig. 1](#F1){ref-type="fig"}*D*). These results show that SsaQ~S~ is not a product of cleavage of SsaQ~L~ and that SsaQ~L~ and SsaQ~S~ are translated independently from the same mRNA species. Consistent with this, there is a purine-rich sequence upstream of the start codon of *ssaQ~S~* (AGAGGATAACACG[ATG]{.ul}), which is likely to be the Shine-Dalgarno sequence for translational initiation ([@B33]).

We next used these strains to examine the involvement of SsaQ~L~ and SsaQ~S~ in SPI-2 T3SS function. In the absence of SsaQ~L~ (the *ssaQ* null mutant strain expressing SsaQ~Y206oc~-HA from a plasmid), there was no detectable secretion in minimal medium at pH 5.0 of either the translocon protein SseB or the effector SseJ ([Fig. 1](#F1){ref-type="fig"}*E*). However, the absence of SsaQ~S~ (the *ssaQ* null mutant strain expressing SsaQ~M217L~-HA from a plasmid) did not noticeably affect secretion of SseB or SseJ at pH 5.0 ([Fig. 1](#F1){ref-type="fig"}*E*). This result indicates that SsaQ~M217L~-HA is functional and that SsaQ~L~ is essential for the SPI-2 T3SS, whereas SsaQ~S~ is not.

#### SsaQ~S~ Is Required for Efficient Secretion of Translocon and Effector Proteins

To further investigate the possible function of SsaQ~S~, the point mutation for M217L was introduced into the chromosomal *ssaQ* gene to create a mutant in which SsaQ~L~ is produced as a result of expression from chromosomal DNA but in which SsaQ~S~ is lacking. In minimal medium at pH 5.0, the mutant displayed highly reduced secretion of all three translocon proteins: SseB, SseC, and SseD ([Fig. 2](#F2){ref-type="fig"}*A*). The decreased secretion of these proteins in the *ssaQ~S~* mutant was restored to wild-type levels by introduction of a plasmid expressing either *ssaQ~S~* or *ssaQ~L~* ([Fig. 2](#F2){ref-type="fig"}*A*). The ability of overexpressed SsaQ~L~ to compensate for loss of SsaQ~S~ was also evident when *ssaQ~L~* was overexpressed in the *ssaQ* mutant ([Fig. 1](#F1){ref-type="fig"}*E*). These results indicate that SsaQ~S~ is required for the efficient secretion of translocon proteins and that overexpression of SsaQ~L~ can compensate for the loss of SsaQ~S~.

![**Role of SsaQ~S~ in secretion of translocon and effector proteins.** The *ssaQ* gene of the wild-type strain of sv. Typhimurium was replaced with *ssaQ~Y206oc~* or *ssaQ~M217L~* to create the *ssaQ~L~* (HH229) or *ssaQ~S~* (HH228) mutant, respectively, and used for secretion assays. *A*, secretion of translocon proteins. Bacterial strains were grown for 5 h in MgM/MES at pH 5.0 for analysis. *B*, secretion of effector SseJ-2HA upon pH shift. Strains expressing SseJ-2HA from chromosomal DNA were grown for 4 h in MgM/MES at pH 5.0 to activate SPI-2 T3SS and then changed to MgM/MES at the indicated pH and incubated for another 1.5 h. *C*, secretion of effector SteC-2HA upon pH shift. Strains carrying plasmid p*steC-2HA* were used for pH shift analysis. Secretion of translocon protein SseB was used as an additional control.](zbc0481183410002){#F2}

To examine the potential role of SsaQ~S~ in secretion of effector proteins, the secretion of epitope-tagged SseJ-2HA was investigated following shift of ambient pH from 5.0 to 7.2, which stimulates effector secretion from the SPI-2 T3SS ([@B4]). Bacterial strains were first grown in minimal medium at pH 5.0 for 4 h to activate the T3SS and then incubated in the same medium at pH 5.0 or 7.2 for 1.5 h. Secreted fractions and whole cell lysates were subjected to SDS-PAGE and immunoblotting. In response to the pH shift, the wild-type and *ssaQ~S~* mutant strains complemented with either *ssaQ~L~* or *ssaQ~S~* displayed greatly enhanced and similar levels of SseJ-2HA secretion, respectively ([Fig. 2](#F2){ref-type="fig"}*B*). In contrast, quantification of the amount of SseJ-2HA secreted by the *ssaQ~S~* mutant showed that it was ∼44% of the wild-type level ([Fig. 2](#F2){ref-type="fig"}*B*). Mutation of *ssaQ~S~* caused a similar reduction in the secreted levels of another effector, SteC-2HA ([Fig. 2](#F2){ref-type="fig"}*C*). These findings indicate that the translocon-to-effector switch mediated by the SsaL-SpiC-SsaM complex in response to pH shift ([@B4]) still occurs in the absence of SsaQ~S~, but the overall efficiency of secretion through the SPI-2 T3SS is reduced *in vitro*.

#### SsaQ~S~ Is Required for Efficient Translocation of Effectors

We next examined whether SsaQ~S~ contributes to effector translocation in infected cells. To do this, HeLa cells were infected for 13 h with different strains expressing the epitope-tagged effector SseJ-2HA from the bacterial chromosome, and the levels of translocation were quantified by flow cytometry. The *ssaQ~L~* mutant was unable to translocate SseJ-2HA. The levels of translocated SseJ-2HA from the *ssaQ~S~* mutant bearing the complementing plasmid p*ssaQ~S~* or p*ssaQ~L~* were similar to those from the wild-type strain, but the *ssaQ~S~* mutant translocated noticeably less SseJ-2HA ([Fig. 3](#F3){ref-type="fig"}). Quantification of the amount of SseJ-2HA translocated by the *ssaQ~S~* mutant showed that it was ∼50% of the wild-type level. We concluded that SsaQ~S~ is required for efficient translocation of SPI-2 T3SS effectors in infected host cells.

![**Flow cytometric analysis of translocation of SseJ-2HA.** HeLa cells were infected for 13 h with bacterial strains expressing SseJ-2HA from chromosomal DNA except for the HA-negative wild-type strain and labeled with antibodies for flow cytometric assay. *A*, intracellular bacteria were detected with anti-*Salmonella* antibody (FL1). *B*, translocated SseJ-2HA was detected with anti-HA antibody (FL4).](zbc0481183410003){#F3}

#### SsaQ~S~ Interacts with and Stabilizes SsaQ~L~

The observation that overexpression of SsaQ~L~ compensates for the loss of SsaQ~S~ suggested that SsaQ~S~ might function as a chaperone, stabilizing SsaQ~L~. To test if SsaQ~S~ interacts with SsaQ~L~, the *ssaQ* mutant strain containing plasmid p*ssaQ-HA* (which produces both SsaQ~L~-HA and SsaQ~S~-HA) and either p*ssaQ~S~-T7* or the empty vector (pACYC184) was grown in minimal medium at pH 5.0. Lysates were incubated with an antibody against T7 to immunoprecipitate SsaQ~S~-T7. SsaQ~L~-HA and SsaQ~S~-HA were not co-immunoprecipitated in the negative control strain containing plasmids p*ssaQ-HA* and pACYC184. However, both SsaQ~L~-HA and SsaQ~S~-HA were co-immunoprecipitated from the strain containing p*ssaQ-HA* and p*ssaQ~S~-T7* ([Fig. 4](#F4){ref-type="fig"}*A*). This result suggested that SsaQ~S~ interacts with the C-terminal domain (SsaQ~S~ region) of SsaQ~L~. To test this, a plasmid expressing the N-terminal 216 amino acids of SsaQ~L~ (*pssaQ~LN216~-HA*) was transformed into the *ssaQ* mutant containing plasmid p*ssaQ~S~-T7*, and following growth in minimal medium at pH 5.0, bacterial lysates were subjected to immunoprecipitation with an antibody against the HA tag. As a positive control, this antibody was shown to co-immunoprecipitate SsaQ~S~-T7 in the strain containing plasmids p*ssaQ-HA* and p*ssaQ~S~-T7* ([Fig. 4](#F4){ref-type="fig"}*B*). However, the antibody did not immunoprecipitate SsaQ~S~-T7 in the *ssaQ* mutant containing *pssaQ~LN216~-HA* and p*ssaQ~S~-T7* ([Fig. 4](#F4){ref-type="fig"}*B*). In addition, a cross-linking experiment showed that SsaQ~S~ homodimerizes following its production in *E. coli* ([Fig. 4](#F4){ref-type="fig"}*C*). These experiments provided evidence that SsaQ~S~ interacts with the corresponding region of SsaQ~L~. Next, we tested if SsaQ~L~ oligomerizes in the absence of SsaQ~S~. To do this, plasmids expressing SsaQ~L~-T7 and either SsaQ~L~-HA or SsaQ~LN216~-HA were transformed into the *ssaQ* mutant and subjected to immunoprecipitation with the anti-HA antibody. SsaQ~L~-T7 was co-precipitated in the presence of SsaQ~L~-HA but not by the N-terminal 216 amino acids of SsaQ~L~ ([Fig. 4](#F4){ref-type="fig"}*D*). Therefore, the SsaQ~S~ region of SsaQ~L~, but not SsaQ~S~ itself, is required for SsaQ~L~ to oligomerize.

![**SsaQ~S~ functions as a chaperone for SsaQ~L~.** *A*, SsaQ~S~ interacts with SsaQ~L~ and itself. Bacterial strain *ssaQ* p*ssaQ-HA* was cotransformed with p*ssaQ~S~-T7* or vector pACYC184, grown for 5 h in MgM/MES at pH 5.0, and then lysed for co-immunoprecipitation. Membranes were probed with antibodies against T7 to detect SsaQ~S~-T7 or HA to detect SsaQ~L~-HA and SsaQ~S~-HA. *B*, the C-terminal region of SsaQ~L~ is required for interaction with SsaQ~S~. Bacterial strain *ssaQ* p*ssaQ~S~-T7* was cotransformed with p*ssaQ-HA* or p*ssaQ~LN216~-HA* and used for co-immunoprecipitation. *C*, dimerization of SsaQ~S~. *E. coli* BL21(DE3) cells containing pET-*ssaQ~S~* were subjected to treatment with the cross-linker disuccinimidyl suberate (DSS) or DMSO and then analyzed by immunoblotting. *D*, the C-terminal region of SsaQ~L~ is required for self-interaction. The *ssaQ* mutant (HH225) was transformed with the indicated plasmids and used for immunoprecipitating HA-tagged protein. Samples were analyzed by immunoblotting. *E*, stabilization of SsaQ~L~ requires SsaQ~S~. The *ssaQ* gene in the wild-type strain was replaced with *ssaQ~M217L~-HA* to create the *ssaQ~L~-HA* strain (HH232) and transformed with p*ssaQ~S~* or vector pWSK29 for analysis. Transformants were cultured for 4 h in MgM/MES at pH 5.0, and tetracycline was added to stop protein synthesis. Samples were taken at the indicated time points for analysis. The band intensities were measured with Image J software and normalized with DnaK to construct the stability curve of SsaQ~L~-HA.](zbc0481183410004){#F4}

To assess the stability of SsaQ~L~ in the absence of SsaQ~S~, a bacterial strain was constructed in which the chromosomal *ssaQ* gene was modified to express SsaQ~M217L~-HA but not SsaQ~S~. This strain was then transformed with p*ssaQ~S~* or the empty vector (pWSK29). The transformants were grown in minimal medium at pH 5.0 to express SsaQ~L~-HA and other SPI-2 proteins. Tetracycline was then added to the growth medium to stop protein synthesis, and samples were taken at different time points to analyze protein stability by SDS-PAGE and immunoblotting. As shown in [Fig. 4](#F4){ref-type="fig"}*E*, SsaQ~L~ was markedly less stable in the absence of SsaQ~S~.

#### Structural Predictions

The level of sequence similarity between SsaQ~S~ and the flagellar C-ring protein FliN ([@B29]) is sufficient for a reliable homology model to be calculated. The template structure of FliN exists as an intimately intertwined dimer that forms a saddle shape ([Fig. 5](#F5){ref-type="fig"}). The homology model of an SsaQ~S~ monomer shows the expected extended β-sheet structure and displays significant solvent exposure of hydrophobic residues, suggesting a higher order organization. The ability of SsaQ~S~ to oligomerize in solution was confirmed by ^1^H NMR spectroscopy (data not shown), in which concentration-independent line-widths of SsaQ~S~ were consistent with a molecular species between ∼20 and ∼40 kDa. These data indicate that SsaQ~S~ probably exists as the intertwined dimer as observed in the crystal structure of FliN.

![**Alignment and three-dimensional structure of SsaQ~S~ and FliN.** *A* and *B*, two orthogonal views of the ribbon representation of the flagellar rotor protein FliN from *T. maritima* (Protein Data Bank code [1YAB](1YAB)). Individual monomers are shown in *pink* and *green. C* and *D*, two orthogonal views of the homology model of the SsaQ~S~ dimer. Individual monomers are shown in *blue* and *red. E*, superposition of the FliN (*gray*) and SsaQ~S~ (*blue*/*red*) dimer structures. *F*, sequence alignment of SsaQ~S~ and FliN.](zbc0481183410005){#F5}

#### SsaQ~S~ Contributes to sv. Typhimurium Virulence

Because SsaQ~S~ is required to stabilize SsaQ~L~ and because SsaQ~L~ is an essential component of the SPI-2 T3SS, we tested if SsaQ~S~ contributes to virulence by CI analysis ([@B30]) involving mixed infections of the wild-type and *ssaQ~S~* mutant strains in the sv. Typhimurium/mouse model of systemic disease. Approximately 5 × 10^2^ colony-forming units of each strain were combined and used to inoculate BALB/c mice by the intraperitoneal route. Infection was allowed to proceed for 4 days, at which time mice were killed, and spleens were homogenized and plated onto rich medium to determine the colony-forming units of each strain. The resulting CI was 0.206 ± 0.133, indicating that the *ssaQ~S~* mutant strain is attenuated in virulence. The virulence defect was fully complemented by introducing p*ssaQ~S~* into the mutant strain and determining its CI in relation to the wild-type strain (CI 0.910 ± 0.212, *p* = 0.0013) and partially complemented by introducing p*ssaQ~L~* into the mutant strain (CI of 0.448 ± 0.067, *p* = 0.0171). This showed that SsaQ~S~ contributes to sv. Typhimurium virulence in the mouse model of infection. The partial complementation of virulence by overexpression of SsaQ~L~ in the *ssaQ~S~* mutant suggested either that SsaQ~S~ has an additional function or that overexpressing SsaQ~L~ somehow affects the virulence of sv. Typhimurium. To test this, we measured the virulence of the *ssaQ~L~* mutant carrying p*ssaQ~L~* compared with the wild-type strain in mice. The resulting CI was 0.317 ± 0.10, significantly lower than 1 (*p* = 0.0008) but significantly higher than the CI obtained from the *ssaQ~L~* mutant strain mixed with the wild-type strain (0.013 ± 0.005, *p* = 0.0009). This indicates that overexpressing SsaQ~L~ in sv. Typhimurium affects its virulence in the mouse model of infection.

DISCUSSION
==========

In this work, we discovered that the *ssaQ* gene of sv. Typhimurium SPI-2 encodes two proteins: the predicted full-length protein SsaQ~L~, composed of 322 amino acids, and the shorter protein SsaQ~S~, comprising the C-terminal 106 residues of SsaQ~L~. SsaQ~L~ is essential for SPI-2 T3SS function, whereas SsaQ~S~ stabilizes SsaQ~L~ and augments the activity of the T3SS.

Site-directed mutagenesis and promoter analysis revealed that SsaQ~S~ is a tandem translated product of *ssaQ*. Tandem translation or "in-frame initiated translation" often occurs in viruses and bacteriophage, where DNA coding capacity is limited, but has rarely been found in bacteria. The few cases reported to date include the widely conserved translational initiation factor IF2 ([@B34]), the chemotactic signaling protein CheA ([@B35]), the heat shock protein ClpB ([@B36]), and the methylation-dependent endonuclease component McrB from *E. coli* ([@B37]). It is also possible that the flagellar secretion system component FliO from *Salmonella* is tandemly translated, but this has not yet been shown in wild-type cells ([@B38]). To our knowledge, SsaQ~S~ represents the first example of a bacterial virulence factor produced by tandem translation and of a chaperone produced by this process.

The finding that SsaQ~L~ is required for secretion of translocon proteins and effectors is not surprising given its sequence similarity to C-ring components of other bacteria. Homologs of SsaQ~L~, including Spa33 from *Shigella* and YscQ from *Yersinia*, are C-ring proteins that interact with components of the secretion machinery, including the ATPase and its regulators ([@B16], [@B39]), and are necessary for formation of the needle structure of the T3SS ([@B16]) and assembly of the associated complex between ATPase and the C-ring ([@B17]). We have also observed that SsaQ~L~ interacts with the putative SPI-2 T3SS ATPase SsaN.[^3^](#FN4){ref-type="fn"} Therefore, SsaQ~L~ is very likely to be an essential C-ring component of the SPI-2 secretion machinery.

In the flagellar C-ring, FliN interacts with the C-terminal region of FliM (FliM~248--334~), where the two proteins show sequence similarity ([@B40]). A similar situation is found in the related HrcQ~B~ and HrcQ~A~ proteins of the *Pseudomonas syringae* pv. phaseolicola T3SS ([@B41]). Here, the C-terminal region of the smaller HrcQ~B~ protein interacts with the C-terminal region of HrcQ~A~. However, the precise role of HrcQ~B~ in the function of the *P. syringae* T3SS is not clear. Structural studies have revealed that FliN forms a tetramer that links molecules of FliM to create a large repeating structure that comprises the lower region of the flagellar C-ring ([@B42]). FliN is thus an integral component of the C-ring. The obvious similarities between SsaQ~S~ and FliN ([Fig. 5](#F5){ref-type="fig"}) and our finding that SsaQ~S~ interacts with an identical region in a larger protein that is predicted to be part of the SPI-2 T3SS C-ring suggested that SsaQ~S~ is also a C-ring protein that could act as a bridge between molecules of SsaQ~L~ to form a repeating unit at the bottom of the C-ring ([@B42]). Although this remains a possibility, two results suggest otherwise. First, it is clear that the SPI-2 T3SS is partially functional in the absence of SsaQ~S~ and that the secretion and translocation defects can be completely overcome *in vitro* and in infected cells by overexpression of SsaQ~L~ ([Figs. 2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}). This contrasts with the situation in the flagellar system, where FliN has an essential role in C-ring formation and flagellum assembly ([@B43], [@B44]). Second, we have shown that SsaQ~L~ can oligomerize in the absence of SsaQ~S~. Instead, our data show that SsaQ~S~ has a chaperoning function by binding to its corresponding region within SsaQ~L~, stabilizing the larger protein. Consistent with this, SsaQ~S~ has a predicted molecular mass of 11.7 kDa and an acidic pI (4.7), features that typify many chaperones ([@B45]). It is possible that SsaQ~L~ and SsaQ~S~ heterodimerize, in which case SsaQ~S~ would assist in the proper folding of SsaQ~L~ or prevent self-polymerization or degradation of SsaQ~L~ before it docks to the T3SS apparatus. Once there, a conformational change induced by interaction with component(s) of the apparatus might lead to the dissociation of the heterodimer. In another scenario, a tetramer could be constructed from SsaQ~S~ homodimers interacting with SsaQ~L~ dimers. The fact that the two SsaQ variants are cotranslated from the same transcript would favor the formation of a heterodimer, as the two proximal polypeptides would fold and dimerize together as they simultaneously exited from ribosomes. It is conceivable that, during assembly of higher order structures, SsaQ~L~ then displaces SsaQ~S~ to construct the mature active SPI-2 T3SS.

To our knowledge, SsaQ~S~ is the first example of a chaperone for a C-ring protein. It is interesting to note that, in the T3SSs encoded by *Salmonella* SPI-1, *Shigella*, and *Yersinia*, there is no evidence for the presence for a small C-ring protein that would correspond to FliN or SsaQ~S~, suggesting that the C-rings of these T3SSs could assemble through direct oligomerization of their SsaQ~L~ homologs (SpaO, Spa33, and YscQ, respectively). Structural studies on SsaQ~L~ are now required to reveal the architecture and to help understand the function of the putative C-ring of the SPI-2 T3SS.
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